QuadMedicine Inc. Q3 operating loss of KRW 3.7 billion on revenue of KRW 25 million
AI summary · Not investment advice
Quadmedicine sold KRW 25 million in Q3 and lost KRW 3.7 billion from its main business, versus sales of KRW 1.9 billion and a loss of KRW 2.6 billion a year earlier.
Operating profit · 3 months
KRW -3.7 billion
Key facts
- Revenue (3 months)
- KRW 25.0 million
- Net income (3 months)
- KRW -3.8 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 1.9 billion
- Revenue (year to date)
- KRW 1.8 billion
- Operating profit (prior-year 3 months)
- KRW -2.6 billion
- Operating profit (year to date)
- KRW -10.5 billion
- Net income (prior-year 3 months)
- KRW -2.6 billion
- Net income (year to date)
- KRW -10.7 billion
Commentary
AI commentary · Not investment advice
What happened
Quadmedicine filed its quarterly report for the third quarter, on a consolidated basis. Sales for the latest 3 months were KRW 25.0 million, down 98.7% from KRW 1.94 billion in the same period a year earlier.
In the company's terms
Operating profit (profit from the core business) for the latest 3 months was a loss of KRW 3.68 billion. A year earlier it was a loss of KRW 2.62 billion. Net income (the final profit after all costs and taxes) for the latest 3 months was a loss of KRW 3.77 billion. A year earlier it was a loss of KRW 2.65 billion.
What changes for shareholders
For the cumulative period from January 1 to September 30, sales were KRW 1.82 billion. Operating profit was a loss of KRW 10.47 billion, and net income was a loss of KRW 10.73 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
Q